Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-001608

ChemoCentryx, Inc. · CCXI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Susan M Kanaya
Officer — EVP, CFO and Sec.
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 1, 2019M20,000$0.00A73,528D
Common StockJan 1, 2019M13,333$0.00A86,861D
Common StockJan 1, 2019M10,000$0.00A96,861D
Common StockF4Jan 1, 2019F24,008$10.91D72,853D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6—Jan 1, 2019M20,000D——Common Stock20,0000D
Restricted Stock UnitsF5,F7—Jan 1, 2019M13,333D——Common Stock13,33313,334D
Restricted Stock UnitsF5,F8—Jan 1, 2019M10,000D——Common Stock10,00020,000D

Explanation of responses